Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

Journal of the American Medical Association

Volumn 284, Issue 15, 2000, Pages 1931-1938

  Holloway, Robert ^a   Shoulson, Ira ^a   Kieburtz, Karl ^a   McDermott, Michael ^a   Tariot, Pierre ^a   Kamp, Cornelia ^a   Day, Denni ^a   Shinaman, Aileen ^a   Fahn, Stanley ^b   Lang, Anthony ^c   Marek, Kenneth ^d   Seibyl, John ^d   Weiner, William ^e   Welsh, Mickie ^e  

^a UNIVERSITY OF ROCHESTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARBIDOPA PLUS LEVODOPA; IODINE 123; LEVODOPA; PRAMIPEXOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISABILITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DYSKINESIA; EDEMA; FEMALE; HALLUCINATION; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOMITING;

EID: 0034684139     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.15.1931     Document Type: Article

References (22)

1. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
2. Evolution of motor fluctuations in Parkinson's disease: A longitudinal study over 6 years
3. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole of levodopa
4. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial
5. Functional roles for dopamine-receptor subtypes
6. Safety and efficacy of pramipexole in early parkinson disease: A randomized dose-ranging study
7. Pramipexole in patients with early Parkinson's disease
8. Dopaminergic dysfunctin in parkinsonism: New lessons from imaging
9. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity
10. A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: Design and methods of the CALM-PD Study
11. Parkinsonism: Onset, progression and mortality
12. DATATOP: A multi-center controlled clinical trial in early Parkinson's disease
13. Assessment of Parkinson's disease
14. Development and testing of the Parkinson's disease quality of life scale: The PDQUALIF
15. EuroQol: A new facility for the measurement of health related quality of life
16. Inter-rater reliability of the Unified Parkinson's Disease Rating Scale motor examination
17. Decreased SPECT [1-1233] β-CIT striatal uptake correlates with symptom severity in idiopathic Parkinson's disease
18. Analysis of clinical trials by treatment actually received: Is it really an option?
19. Preventing levodopa-induced dyskinesias
20. The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's diesease research
21. Falling asleep at the wheel: Motor mishaps in persons taking pramipexole and ropinirole